Handelsbanken Fonder’s Catalyst Pharmaceutical CPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $696K | Sell |
32,077
-3,400
| -10% | -$73.8K | ﹤0.01% | 1109 |
|
|
2025
Q1 | $860K | Hold |
35,477
| – | – | ﹤0.01% | 999 |
|
|
2024
Q4 | $740K | Buy |
35,477
+1,000
| +3% | +$20.9K | ﹤0.01% | 1125 |
|
|
2024
Q3 | $685K | Buy |
34,477
+5,500
| +19% | +$109K | ﹤0.01% | 1104 |
|
|
2024
Q2 | $449K | Buy |
28,977
+3,700
| +15% | +$57.3K | ﹤0.01% | 1205 |
|
|
2024
Q1 | $403K | Hold |
25,277
| – | – | ﹤0.01% | 1264 |
|
|
2023
Q4 | $425K | Sell |
25,277
-2,600
| -9% | -$43.7K | ﹤0.01% | 1224 |
|
|
2023
Q3 | $326K | Buy |
27,877
+13,377
| +92% | +$156K | ﹤0.01% | 1274 |
|
|
2023
Q2 | $195K | Buy |
+14,500
| New | +$195K | ﹤0.01% | 1496 |
|